Radiolabelled Peptides: Eon in Radiopharmaceutical

Author(s): Vikash Kumar, Permender Rathee, Kanchan Kohli, Hema Chaudhary, Sushila Rathee.

Journal Name: Current Radiopharmaceuticals

Volume 2 , Issue 3 , 2009

Become EABM
Become Reviewer

Abstract:

Radiolabelled peptides are of increasing interest in nuclear medicine. Radiolabelled peptides are an emerging class of radiopharmaceuticals that share chemical and biological properties. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the immense contributions of scientists from diverse disciplines such as radiochemistry, inorganic chemistry, organic chemistry, biochemistry, physiology and pharmacology. One of the challenges in the coming years will be to take advantage of the potentials of radiolabelled peptides to formulate clinically useful radiopharmaceuticals. The major constituent of a radiopharmaceutical is the radionuclide and the search for new radionuclides to improve the availability of diagnostic and therapeutic radiopharmaceuticals is continuing. This paper reviews most of the radiolabelled peptides that have been tested in animals and humans.

Keywords: Nuclear medicine, radionuclide, radiolabelled peptide, diagnostic and therapeutic radiopharmaceutical, therapeutic targeting

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 2
ISSUE: 3
Year: 2009
Page: [199 - 213]
Pages: 15
DOI: 10.2174/1874471010902030199
Price: $58

Article Metrics

PDF: 5